Abdominal obesity, cardiometabolic risk and endocannabinoid system

Abdominal obesity, cardiometabolic risk and endocannabinoid system

Abdominal obesity is the most prevalent manifestation of metabolic syndrome and is of central importance in the definition of global cardiometabolic risk. Visceral adipose tissue releases a large number of bioactive mediators, which influence body weight homeostasis, insulin resistance, alterations...

Full description

Bibliographic Details
Main Author: G. Bittolo Bon
Format: Article
Language:English
Published: PAGEPress Publications 2013-05-01
Series:Italian Journal of Medicine
Subjects:
Obesity
Metabolic syndrome
Cardiometabolic risk
Endocannabinoid system
Rimonabant.
Online Access:http://www.italjmed.org/index.php/ijm/article/view/349

Internet

http://www.italjmed.org/index.php/ijm/article/view/349

Similar Items